Replies to post #21 on Neoleukin Therapeutics Inc (NLTX)

[Phosphene]

Currently no FDA-approved exosome products as of 12/6/19.

Perhaps progress/discovery on cytokine mimetics for targeted

immunotherapy?

Old link: https://www.exosome-rna.com/microrna-profiling-of-exosomes-isolated-from-biofluids-and-conditioned-media/